Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 1
Download in electronic PDF format for $75
Abstract: The often-debilitating ulcers that develop on the feet of patients with diabetes (i.e., “diabetic foot ulcers”) are among the most common types of chronic wounds. Their persistent failure to heal despite treatment is a significant cause of morbidity in a patient population often challenged by concomitant health conditions and quality-of-life issues. When a commercially manufactured therapy does not adequately heal such lesions, a compounded formulation may offer an effective alternative. In those customized medications, several drugs with different mechanisms of action can be combined in strengths or titrations compatible with each patient’s pharmacogenomics profile, and the formulation of a compound can be easily altered as healing progresses and/or the patient’s medical needs change. In this first in a series of 2 articles on compounding for the treatment of diabetic foot ulcers, the types, pathophysiologic causes, risk factors, and treatment of those lesions are discussed and formulations that promote their healing are provided. In part 2 of the series, differences in the healing of acute and chronic wounds are examined, the results of pharmacotherapy in treating diabetic foot ulcers are reviewed, the effectiveness of several drugs that promote chronic-wound healing is assessed, and additional formulations effective in treating nonhealing wounds are presented.
Related Keywords:
diabetic foot ulcers, diabetes, chronic wound healing, drug combinations, nonhealing lesions, neuropathic ulcers, ischemic ulcers, neuroischemic ulcers, diabetic neuropathy, peripheral artery disease, arterial neuropathy, peripheral neuropathy, formulations, phenytoin, misoprostol, insulin, naltrexone hydrochloride, lidocaine hydrochloride, nifedipine, topical preparations, risk factors
Related Categories:
DERMATOLOGY, DIABETES, FORMULATIONS, WOUND CARE, DOSAGE FORMS/DRUG CARRIERS
Printer-Friendly Version
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Case Report: Wound Care of a Diabetic Foot Ulcer
Wynn Tom
|
Jul/Aug 2004
Pg. 265-267
|
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 1
Riepl Mike
|
May/Jun 2020
Pg. 182-186
|
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 2
Riepl Mike
|
Jul/Aug 2020
Pg. 278-281
|
Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications
Agbi Kelechi E, Carvalho Maria, Phan Ha, Tuma Cristiane
|
Jan/Feb 2017
Pg. 22-27
|
Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
|
Jul/Aug 2004
Pg. 269-274
|
Profile of a Practice: Ward Drug Company Diabetic Shoppe and Prescription Compounding Center
Vail Jane
|
Jan/Feb 2003
Pg. 21-23
|
Five Compounds for Treating Diabetes-Related Conditions
Meece Jerry
|
May/Jun 2003
Pg. 170-174
|
L-Arginine and Ascorbic Acid for Diabetic Foot Ulcers
Gorman Shellie
|
Mar/Apr 2000
Pg. 94-96
|
Case Report: Wound Care of a Diabetic Foot Ulcer
Wynn Tom, Thompson Chad
|
Nov/Dec 2024
Pg. 455-458
|
A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin
Riepl Mike
|
Mar/Apr 2022
Pg. 94-98
|
Options in Wound Care
Kincaid Michele R
|
Mar/Apr 2002
Pg. 92-95
|
Complications of Diabetes
Key David M
|
Mar/Apr 2000
Pg. 88-90
|
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Riepl Mike
|
Sep/Oct 2022
Pg. 364-368
|
Compounding Pearls -- Wound Care: Burn Healing, Part 2
Riepl Mike
|
Jul/Aug 2020
Pg. 282-285
|
Diabetic Skin-Ulcer Cream
Allen Loyd V Jr
|
Mar/Apr 2000
Pg. 131
|
Misoprostol 0.0024% and Phenytoin 5% Diabetic Ulcer Cream
Meece Jerry
|
May/Jun 2003
Pg. 171
|
Case Report: Topical Gel for the Treatment of a Refractory Leg Ulcer
Israel Alan
|
May/Jun 2003
Pg. 176-178
|
Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone
Riepl Mike
|
Sep/Oct 2021
Pg. 372-377
|
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 4. Insulin
Riepl Mike
|
Nov/Dec 2021
Pg. 468-472
|
Compounding for the Dental Patient: A Focus on Ulcers of the Mouth
Bassani August S, Keim David
|
Nov/Dec 2004
Pg. 436-440
|
Return to Top |